Gregory Sullivan, M.D.
Assistant Professor of Clinical Psychiatry
Member, Institutional Review Board,
New York State Psychiatric Institute
Gregory M. Sullivan, M.D. is an Assistant Professor of Clinical Psychiatry in the Department of Psychiatry at Columbia University. His areas of expertise include the diagnosis, treatment, and neurobiology of anxiety and mood disorders.
Dr. Sullivan received his undergraduate degree from the University of California, Berkeley, and in 1992 he received his medical doctorate from the College of Physicians & Surgeons at Columbia University. He remained at Columbia for residency training in psychiatry, completed a two-year NIH-sponsored research fellowship in anxiety and affective disorders, and, in 1999 he joined the faculty in the Department of Psychiatry. Dr. Sullivan has a particular interest in translational studies of anxiety and depressive disorders, incorporating the knowledge base of brain functioning identified through basic neuroscience research.
In 2003, Dr. Sullivan joined the research division of J. John Mann, M.D. in the Molecular Imaging & Neuropathology Division of the New York State Psychiatric Institute and Columbia University.
His studies focus on the use of positron emission tomography (PET) imaging for determination of key circuitry and neurochemistry underlying anxiety disorders, mood disorders, and comorbid depression and anxiety. Dr. Sullivan has authored or co-authored over 25 articles and chapters. He is a recipient of faculty research grants from the Anxiety Disorders Association of America, the American Foundation for Suicide Prevention, the National Alliance for Research on Schizophrenia and Depression, and the Dana Foundation; and he was awarded K08 career award from the National Institute of Mental Health to pursue PET studies in panic disorder.
He supervises residents of Columbia University's psychiatry residency training program in the clinical care of patients, and he is director of their course on the neurobiological foundations of psychopharmacological treatments.
Undergraduate: University of California, B.A., 1987
Medical School: Columbia University, M.D., 1992
Internship: Columbia Presbyterian Medical Center, Medicine, 1992 - 1993
Residency: NYS Psychiatric Institute, Psychiatry, 1994 - 1997
Fellowship: New York Presbyterian Hospital/New York State Psychiatric Institute, 1997 - 1999
NYS Psychiatric Institute
Room 3619B Unit/Box:41
1051 Riverside Drive
New York, NY 10032
1. Sullivan GM, Oquendo MA, Simpson N, Van Heertum RL, Mann JJ, Parsey RV: Brain serotonin1A receptor binding in major depression is related to psychic and somatic anxiety. Biological Psychiatry 2005;58: 947-54
1. Sullivan GM, Oquendo MA, Huang YY, Mann JJ: Elevated cerebrospinal fluid 5-hydroxyindoleacetic acid levels in women with comorbid depression and panic disorder. International Journal of Neuropsychopharmacology 2005;Nov 1, [Epub ahead of print]: 1-10
1. Sullivan GM, Apergis J, Bush DE, Johnson LR, Hou M, Ledoux JE: Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus. Neuroscience 2004;128: 7-14
1. Sullivan GM, Kent JM, Kleber M, Martinez JM, Yeragani VK, Gorman JM: Effects of hyperventilation on heart rate and QT variability in panic disorder pre- and post-treatment. Psychiatry Research 2004;125: 29-39
1. Sullivan GM, Apergis J, Gorman JM, LeDoux JE: Rodent doxapram model of panic: behavioral effects and c-Fos immunoreactivity in the amygdala. Biological Psychiatry 2003;53: 863-70